UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

RNA interference in the clinic: challenges and future directions

Nature reviews. Cancer, 2011-01, Vol.11 (1), p.59

2011

Link zum Volltext

Verfügbarkeit prüfen

Back to the Future: Rethinking the Great Potential of lncRNAS for Optimizing Chemotherapeutic Response in Ovarian Cancer

Cancers, 2020-08, Vol.12 (9), p.2406

2020

Link zum Volltext

Verfügbarkeit prüfen

Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR‐148a on tumor growth and phenotype and liver fibrosis

Hepatology (Baltimore, Md.), 2016-03, Vol.63 (3), p.864-879

2016

Link zum Volltext

Verfügbarkeit prüfen

Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer

Molecular systems biology, 2014-05, Vol.10 (5), p.728-n/a

2014

Link zum Volltext

Verfügbarkeit prüfen

HSP70 Inhibition Synergistically Enhances the Effects of Magnetic Fluid Hyperthermia in Ovarian Cancer

Molecular cancer therapeutics, 2017-05, Vol.16 (5), p.966-976

2017

Link zum Volltext

Verfügbarkeit prüfen

Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs

Oncotarget, 2017-03, Vol.8 (12), p.20145-20164

2017

Link zum Volltext

Verfügbarkeit prüfen

miRNA Deregulation in Cancer Cells and the Tumor Microenvironment

Cancer discovery, 2016-03, Vol.6 (3), p.235-246

2016

Link zum Volltext

Verfügbarkeit prüfen

Downregulation of the c‐MYC target gene, peroxiredoxin III, contributes to arsenic trioxide‐induced apoptosis in acute promyelocytic leukemia

International journal of cancer, 2009-07, Vol.125 (2), p.264-275

2009

Link zum Volltext

Verfügbarkeit prüfen

Dopamine Blocks Stress-Mediated Ovarian Carcinoma Growth

Clinical cancer research, 2011-06, Vol.17 (11), p.3649-3659

2011

Link zum Volltext

Verfügbarkeit prüfen

An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer

Non-coding RNA, 2023-11, Vol.9 (6), p.70

2023

Link zum Volltext

Verfügbarkeit prüfen

STAMP2 increases oxidative stress and is critical for prostate cancer

EMBO molecular medicine, 2015-03, Vol.7 (3), p.315-331

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors

Gastroenterology (New York, N.Y. 1943), 2011-11, Vol.141 (5), p.1728-1737

2011

Link zum Volltext

Verfügbarkeit prüfen

Role of M₂, M₃, and M₄ muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats

Journal of neurochemistry, 2009-11, Vol.111 (4), p.1000-1010

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer

Human pathology, 2012-10, Vol.43 (10), p.1638-1644

2012

Link zum Volltext

Verfügbarkeit prüfen

RNAi therapies: drugging the undruggable

Science translational medicine, 2014-06, Vol.6 (240), p.240ps7

2014

Link zum Volltext

Verfügbarkeit prüfen

microRNA Therapeutics in Cancer — An Emerging Concept

EBioMedicine, 2016-10, Vol.12 (C), p.34-42

2016

Link zum Volltext

Verfügbarkeit prüfen

Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance

The Journal of clinical investigation, 2018-02, Vol.128 (2), p.589-606

2018

Link zum Volltext

Verfügbarkeit prüfen

Bone protection by inhibition of microRNA-182

Nature communications, 2018-10, Vol.9 (1), p.4108-17, Article 4108

2018

Link zum Volltext

Verfügbarkeit prüfen

FABP4 as a key determinant of metastatic potential of ovarian cancer

Nature communications, 2018-07, Vol.9 (1), p.2923-14, Article 2923

2018

Link zum Volltext

Verfügbarkeit prüfen

Paraneoplastic Thrombocytosis in Ovarian Cancer

The New England journal of medicine, 2012-02, Vol.366 (7), p.610-618

2012

Link zum Volltext

Verfügbarkeit prüfen

TP53 loss creates therapeutic vulnerability in colorectal cancer

Nature (London), 2015-04, Vol.520 (7549), p.697-701

2015

Link zum Volltext

Verfügbarkeit prüfen

Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)

Molecular cancer therapeutics, 2017-06, Vol.16 (6), p.1114-1123

2017

Link zum Volltext

Verfügbarkeit prüfen

Platelets reduce anoikis and promote metastasis by activating YAP1 signaling

Nature communications, 2017-08, Vol.8 (1), p.310-15, Article 310

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 693

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(637)
Mit Volltextzugriff
(642)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(97)
Clinical Cancer Research
(40)
Blood
(20)
Nature Communications
(20)
The Journal Of Clinical Investigation
(18)
Cell Reports
(15)
Oncogene
(13)
Molecular Cancer Therapeutics
(12)
The Journal Of Biological Chemistry
(12)
Cancer Cell
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

RNA interference in the clinic: challenges and future directions

Back to the Future: Rethinking the Great Potential of lncRNAS for Optimizing Chemotherapeutic Response in Ovarian Cancer

Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR‐148a on tumor growth and phenotype and liver fibrosis

Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer

HSP70 Inhibition Synergistically Enhances the Effects of Magnetic Fluid Hyperthermia in Ovarian Cancer

Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs

Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53‐altered tumors

miRNA Deregulation in Cancer Cells and the Tumor Microenvironment

Downregulation of the c‐MYC target gene, peroxiredoxin III, contributes to arsenic trioxide‐induced apoptosis in acute promyelocytic leukemia

Dopamine Blocks Stress-Mediated Ovarian Carcinoma Growth

An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer

STAMP2 increases oxidative stress and is critical for prostate cancer

Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors

Role of M₂, M₃, and M₄ muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats

Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer

RNAi therapies: drugging the undruggable

microRNA Therapeutics in Cancer — An Emerging Concept

Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth

Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance

Bone protection by inhibition of microRNA-182

FABP4 as a key determinant of metastatic potential of ovarian cancer

Paraneoplastic Thrombocytosis in Ovarian Cancer

TP53 loss creates therapeutic vulnerability in colorectal cancer

Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)

Platelets reduce anoikis and promote metastasis by activating YAP1 signaling

Suchergebnisse filtern